Background In the phase 1–2 portion of an adaptive trial, REGEN-COV, a combination of the
monoclonal antibodies casirivimab and imdevimab, reduced the viral load and number of …

Background Recent data suggest that complications and death from coronavirus disease
2019 (Covid-19) may be related to high viral loads. Methods In this ongoing, double-blind, …

Background REGEN-COV (previously known as REGN-COV2), a combination of the monoclonal
antibodies casirivimab and imdevimab, has been shown to markedly reduce the risk of …

Colon cancer stem cells are believed to originate from a rare population of putative CD133
+ intestinal stem cells. Recent publications suggest that a small subset of colon cancer cells …

Myelosuppression damages the bone marrow (BM) vascular niche, but it is unclear how
regeneration of bone marrow vessels contributes to engraftment of transplanted hematopoietic …

The mechanisms through which hematopoietic cytokines accelerate revascularization are
unknown. Here, we show that the magnitude of cytokine-mediated release of SDF-1 from …

Bone marrow endothelial cells (ECs) are essential for reconstitution of hematopoiesis, but
their role in self-renewal of long-term hematopoietic stem cells (LT-HSCs) is unknown. We …

The bone marrow vasuclar niche consists of a network of thin-walled and fenestrated sinusoidal
vessels whose integrity is maintained and supported by surrounding hematopoietic cells…

The insulin-like growth factor I receptor (IGF-IR) is overexpressed in many diverse tumor
types and is a critical signaling molecule for tumor cell proliferation and survival. Therapeutic …

Monoclonal antibodies against SARS-CoV-2 are a clinically validated therapeutic option
against COVID-19. Because rapidly emerging virus mutants are becoming the next major …